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Abstract
Aims:  Obese subjects with insulin resistance and hypertension have abnormal aortic elastic
function, which may predispose them to the development of left ventricular dysfunction. We
hypothesised that obesity, uncomplicated by other cardiovascular risk factors, is independently
associated with aortic function.
Methods and results: We used magnetic resonance imaging to measure aortic compliance,
distensibility and stiffness index in 27 obese subjects (BMI 33 kg/m2) without insulin resistance and
with normal cholesterol and blood pressure, and 12 controls (BMI 23 kg/m2). Obesity was
associated with reduced aortic compliance (0.9 ± 0.1 vs. 1.5 ± 0.2 mm2/mmHg in controls, p < 0.02)
and distensibility (3.3 ± 0.01 vs. 5.6 ± 0.01 mmHg-1 × 10-3, p < 0.02), as well as higher stiffness index
(3.4 ± 0.3 vs. 2.1 ± 0.1, p < 0.02). Body mass index and fat mass were negatively correlated with
aortic function. Leptin was higher in obesity (8.9 ± 0.6 vs. 4.7 ± 0.6 ng/ml, p < 0.001) and also
correlated with aortic measures. In multiple regression models, fat mass, leptin and body mass
index were independent predictors of aortic function.
Conclusion: Aortic elastic function is abnormal in obese subjects without other cardiovascular
risk factors. These findings highlight the independent importance of obesity in the development of
cardiovascular disease.
Introduction
Obesity affects approximately 300 million people world-
wide, and another 750 million are believed to be over-
weight [1], representing one of the largest health care
challenges of our time. Obesity is associated with high lev-
els of adiposity, significantly increased levels of adipok-
ines such as leptin [2] and elevated levels of the
inflammatory marker C-reactive protein (CRP) [3]. Land-
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mark studies have linked obesity with a higher risk of
developing heart failure [4].
Subjects with obesity have altered aortic function [3,5,6].
Physiologically, the aorta maintains low left ventricular
after-load, promotes optimal sub-endocardial coronary
blood flow [7], and transforms pulsatile into more lami-
nar blood flow. Increased aortic stiffness leads to higher
left ventricular systolic pressures, diminished sub-endo-
cardial blood supply [7] and may ultimately contribute to
left ventricular dysfunction [8,9]. These changes in arterial
mechanics are also associated with coronary artery disease
[10], hypertension [11,12], diabetes [13,14], and hyperc-
holesterolaemia [15-17]; disorders which themselves are
more common in obesity Therefore, it has been difficult
to determine the independent effect of obesity on vascular
function.
In this study, we employed the unique features of cardio-
vascular magnetic resonance imaging – direct visualisa-
tion of cardiac and aortic mechanics, with high temporal
and spatial resolution, even in subjects with large subcu-
taneous thoracic fat deposits [18,19] – to test the hypoth-
esis that obesity is independently associated with
abnormal aortic function, in adults without confounding
factors such as diabetes, insulin resistance, hypertension,
or coronary artery disease.
Methods
Subjects
Control and obese subjects were recruited from the gen-
eral population of Oxfordshire via newspaper advertise-
ments. The study was approved by the local ethics
committee, and subjects gave their informed consent
prior to participation.
Blood assays
Participants had fasting venous blood samples collected
to assess hepatic and renal function, full blood count,
lipid profile, insulin, glucose, C reactive protein (CRP)
and leptin. Lipid profile was based on total cholesterol,
high density lipoproteins (HDL), triglycerides and a calcu-
lated low density lipoprotein (LDL) level [20]. Leptin
(LINCO Research Inc., St. Charles Missouri) and C reac-
tive protein (CRP) (MP Biomedicals, Orangeburg, NY)
were measured using commercially available ELISA tech-
niques.
Exclusion criteria
To investigate the independent effect of obesity on aortic
function, we excluded patients with cardiovascular risk
factors or factors that might contribute to sub-optimal
vascular function. Hypertensives were identified and
excluded based on the Joint National Council on Preven-
tion, Detection, Evaluation and Treatment of High Blood
Pressure definitions [21]. Diabetics were identified from
medical history or fasting venous blood glucose level ≥
6.7 mmol/L [22]. Furthermore, the homeostasis insulin
model assessment (HOMA) formula was used to calculate
an insulin resistance (IR) score [23]. Men with an IR score
of > 2.35 and women with a score > 1.88 were excluded
based on the European Group for the study of Insulin
Resistance (EGIR) guidelines [24]. Smokers, subjects with
a history of cerebrovascular or coronary artery disease,
those with total blood cholesterol levels > 6 mmol/L and
those with abnormal renal, hepatic or haematological
function were not included. Additionally, those with con-
traindications to CMR were not recruited.
Assessment of body size
All participants were weighed on an electronic Seca scale
and height was measured on an adjustable Seca standing
stadiometer. These measures were used to calculate body
mass index. Waist and hip circumferences were measured
using a tape measure. Bioelectric impedance using the
Bodystat® 1500 was used to assess fat mass.
Cardiovascular magnetic resonance imaging
CMR studies were performed on a 1.5 Tesla clinical MR
system (Siemens Sonata, Erlangen, Germany) as previ-
ously described [25]. For aortic imaging, a 2-element array
surface coil on the chest was combined with a spine-coil
array. Aortic indices were assessed using TrueFISP cine
sequences with the following parameters: TR/TE 2.8 ms/
1.4 ms and 15 lines per phase with a temporal resolution
of 24 frames per second. Sampling bandwidth was 930
Hz/pixel with a matrix of 192 × 118 over a FoV of 380 ×
332 mm, resulting in an in-plane resolution of 1.97 × 2.81
mm. Aortic cine images were acquired in two transverse
planes, based on sagittal-oblique pilots (Figure 1a): at the
pulmonary arch for the ascending and descending aorta
and 10 cm below the diaphragm for the distal descending
aorta (Figure 1b and 1c). All participants had their resting
blood pressure taken immediately before the cardiac mag-
netic resonance study. For cardiac analysis localiser
images were acquired followed by vertical long axis (VLA)
and horizontal long axis (HLA) cine images. A short axis
stack of contiguous images was then acquired (slice thick-
ness 7 mm, inter-slice gap 3 mm).
Aortic cross-sections were manually contoured using CMR
Tools® (Imperial College, London, UK). Vascular compli-
ance, distensibility and stiffness index were calculated as
described previously [18]. Aortic compliance is the abso-
lute change in area per unit of pressure whereas distensi-
bility is the relative change per unit pressure. Stiffness
index examines the logarithmic relationship between
pressure and the relative change in aortic cross-sectional
area. This takes into account the variation in background
arterial distending pressure. Mean aortic compliance, dis-Journal of Cardiovascular Magnetic Resonance 2008, 10:10 http://www.jcmr-online.com/content/10/1/10
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tensibility and stiffness index were calculated by averaging
the regional measures. Left ventricular volumes and mass
were obtained from the short axis stack by manually con-
touring end-diastolic and end-systolic endocardial and
epicardial borders from base to apex, using Siemens ana-
lytical software (ARGUS©). Left ventricular end-diastolic
volume (EDV), end-systolic volume (ESV), left ventricular
mass (LVM), ejection fraction (EF), stroke volume (SV)
and cardiac output (CO) were calculated and, where
appropriate, normalised for body size.
Statistical analysis
Statistical analysis was carried out using SPSS 11.0. Arte-
rial compliance, distensibility, stiffness index and myocar-
dial mass were not normally distributed and were
investigated using non-parametric Mann-Whitney test
and Spearman's analysis for correlation. All values are
reported as mean ± the standard error of the mean (SEM)
and a p value of < 0.05 was considered significant. Multi-
ple linear regression was carried out correcting for gender
and height to determine predictors of aortic function.
Results
Demographic characteristics of the study groups are in
Table 1. Ages and lean mass of obese and lean subjects
were not different. The obese group were shorter, with a
1.4 times higher BMI (p < 0.01) and 1.9 times higher fat
mass (p < 0.01). There was no significant difference
between groups in waist-hip ratio, systolic (SBP) or
diastolic blood pressure (DBP) or mean arterial pressure.
Blood parameters (Table 2)
There was no significant difference in total or LDL choles-
terol levels between groups. Triglyceride levels were 31%
higher in the obese (p < 0.05) and HDL levels 13% lower
(p < 0.05). Leptin levels were 91% higher in the obese (p
< 0.01) whereas CRP levels were not significantly differ-
ent. Fasting glucose levels were similar between groups.
Insulin levels were higher in the obese, but HOMA insulin
resistance scores did not vary. BMI correlated positively
with leptin (r = 0.8, p < 0.001) and CRP (r = 0.6, p < 0.001)
and negatively with HDL (r = -0.7, p < 0.001). Fat mass
showed positive correlations with leptin (r  = 0.8, p  <
0.001) and CRP (r = 0.5, p = 0.001), and negative correla-
tion with HDL cholesterol (r = -0.5, p < 0.001).
Left ventricular function
There was no difference in ejection fraction between
groups. The control cohort was taller and had larger car-
diac volumes. However, there were no significant differ-
ences between cohorts in SV, EDV, ESV, and LVM indexed
for height (Table 3).
Table 1: Demographic data-obese and control group
Control Subjects Obese Subjects
Sample size 12 27
Age (y) 53 ± 10 49 ± 11
Male: Female 8:4 13:14
Weight (kg) 75.0 ± 12.6 98.3 ± 19.7†
Height (m) 1.8 ± 0.01 1.70 ± 0.01*
BMI (kg/m2) 23.9 ± 2.7 33.8 ± 3.0†
Fat Mass (kg) 20.2 ± 6.8 38.3 ± 11.9†
Lean Mass (kg) 54.0 ± 14.9 57.6 ± 14.5
WC (cm) 86 ± 8 113 ± 15 *
WHR 0.9 ± 0.01 1.0 ± 0.01
SBP (mmHg) 127 ± 10 130 ± 9
DBP (mmHg) 76 ± 9 80 ± 8
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; MAP, mean arterial pressure; WC, waist 
circumference; WHR, waist hip ratio. *p < 0.05, †p < 0.01. Data are 
presented as means ± standard deviation.
CMR image in coronal-sagittal orientation indicating meas- urement levels in the aorta (a) Figure 1
CMR image in coronal-sagittal orientation indicating 
measurement levels in the aorta (a). AAO indicates 
ascending aorta; DAOP, proximal descending aorta; DAOD, 
distal descending aorta. Transverse CMR images demonstrat-
ing the ascending and proximal descending aorta (b, c) and 
the distal descending aorta (d, e) in systole and diastole.Journal of Cardiovascular Magnetic Resonance 2008, 10:10 http://www.jcmr-online.com/content/10/1/10
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Aortic function and obesity (Table 4)
Obesity was associated with a significant reduction in
compliance in the proximal descending thoracic aorta and
the distal descending abdominal aorta (Figure 1). Further-
more, there was a corresponding decrease in distensibility
of the proximal descending aorta and distal descending
aorta. Stiffness index (β) was significantly higher in the
obese at the level of the distal descending aorta only.
There was no significant difference between groups in aor-
tic compliance, distensibility or stiffness index in the
ascending aorta.
Conventional indicators of obesity were significantly cor-
related with aortic function. Mean aortic compliance in
the obese was 40% lower (0.99 ± 0.11 vs. 1.45 ± 0.15
mm2/mmHg,  p  = 0.021) and distensibility 59% lower
(3.3 ± 0.004 vs. 5.6 ± 0.001 mmHg-1 × 10-3, p = 0.023).
Compliance showed significant negative correlations with
BMI (r = -0.48 p = 0.003), fat mass (r = -0.55, p = 0.001),
and leptin (r = -0.47, p = 0.005) (Figure 2) and significant
positive correlations with HDL (r = 0.66, p < 0.001). Aor-
tic distensibility correlated negatively with BMI (r = -0.51,
p = 0.002) (Figure 3a), and fat mass (r = -0.58, p < 0.001)
(Figure 3b). HDL showed a significant positive correlation
with distensibility (r = 0.47, p = 0.008).
There was also a negative correlation noted between waist
circumference and aortic compliance (r = -0.53, p = 0.001)
and distensibility (r = -0.56, p = <0.001). There were no
significant correlations between waist-hip ratios and
measures of aortic compliance (r = -0.06, p = 0.75) or dis-
tensibility (r = -0.06, p = 0.75).
Determinants of aortic function
Using independent multiple linear regression analysis, a
significant negative linear relationship was found
between aortic compliance and leptin (Regression Coeffi-
cient (RC) = -0.017, 95% Confidence Intervals (CI) = -
0.027 to -0.007 p = 0.002), fat mass (RC = -0.029, 95% CI
= -0.042 to -0.015, p < 0.001), and BMI (RC = -0.045,
95%CI = -0.70 to -0.020, p  = 0.001). On the basis of
adjusted r square analysis, fat mass emerged as the strong-
est predictor of aortic compliance. A significant positive
association was noted between aortic compliance and
HDL cholesterol (RC = 0.873, 95%CI = 0.278 to 1.468, p
= 0.006). Distensibility was similarly determined by fat
mass (RC = -0.041, 95%CI = -0.057 to -0.026, p < 0.001),
BMI (RC = -0.060, 95%CI = -0.09 to -0.03, p < 0.001) and
leptin (RC = -0.019 × 10-2, 95%CI = -0.32 to -0.005, p =
0.008). HDL (RC = 1.309, 95%CI = 0.596 to 2.020, p =
0.001) was positively associated with distensibility. There
was no significant relationship demonstrated between
CRP, insulin or insulin resistance and aortic function.
Thus, fat mass, leptin and BMI emerged as the main pre-
dictors of abnormal aortic function in this population.
Discussion
In this study, cardiovascular magnetic resonance imaging
revealed significant changes in aortic mechanical function
in an obese population without hypertension, diabetes,
Table 4: Regional aortic elastic function – obese and control 
groups
Control Subjects Obese Subjects
AAO Compliance 
(mm2/mmHg)
2.04 ± 0.23 1.69 ± 0.26
AAO Distensibility 
(mmHg-1 × 10-3)
3.60 ± 0.44 3.30 ± 0.63
AAO Stiffness index 2.33 ± 0.1 2.55 ± 0.2
DAOP Compliance 
(mm2/mmHg)
1.40 ± 0.17 0.83 ± 0.15*
DAOP Distensibility 
(mmHg-1 × 10-3)
5.00 ± 0.7 3.20 ± 0.5†
DAOP Stiffness index 2.06 ± 0.1 2.89 ± 0.3
DAOD Compliance 
(mm2/mmHg)
0.93 ± 0.18 0.56 ± 0.12‡
DAOD Distensibility 
(mmHg-1 × 10-3)
8.10 ± 0.3 3.60 ± 0.7*
DAOD Stiffness index 1.89 ± 0.3 4.00 ± 0.6‡
AAO, ascending aorta; DAOP, proximal descending thoracic aorta;
DAOD, descending (abdominal) aorta. Data are presented as mean ± 
standard error of the mean. *p = 0.02, † p = 0.03, ‡ p = 0.04
Table 2: Biochemical assays-obese and control groups
Control Subjects Obese Subjects
Total Cholesterol (mmol/L) 4.94 ± 0.12 4.93 ± 0.15
HDL Cholesterol (mmol/L) 1.53 ± 0.1 1.17 ± 0.05*
LDL Cholesterol (mmol/L) 2.95 ± 0.20 3.09 ± 0.21
Triglycerides (mmol/L) 1.00 ± 0.11 1.31 ± 0.12*
Fasting Glucose (mmol/L) 5.07 ± 0.09 5.0 ± 0.11
Insulin (μmol/L) 2.91 ± 0.33 4.69 ± 0.56*
HOMA 0.61 ± 0.09 0.65 ± 0.12
Leptin (ng/ml) 4.69 ± 0.57 8.98 ± 0.58†
CRP (mg/L) 3.47 ± 0.47 5.26 ± 0.56
HOMA, homeostasis insulin model assessment; CRP, C reactive 
protein. *p < 0.05, †p < 0.01. Data are presented as means ± standard 
error of the mean.
Table 3: Left ventricular function-obese and control groups
Control Subjects Obese Subjects P value
EF (%) 65 ± 2 63 ± 3 0.7
ESV index (ml/m) 28 ± 2 26 ± 1 0.5
EDV index (ml/m) 81 ± 5 70 ± 3 0.1
SV index (ml/m) 53 ± 4 45 ± 3 0.1
LVM index (g/m) 81 ± 6 87 ± 4 0.4
Data are presented as mean ± standard error of the mean. All data 
represent height indexed values. ESV, end-systolic volume; EDV, end-
diastolic volume;SV, stroke volume; EF, ejection fraction, LVM, left 
ventricular mass.Journal of Cardiovascular Magnetic Resonance 2008, 10:10 http://www.jcmr-online.com/content/10/1/10
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insulin resistance or hypercholesterolaemia. The descend-
ing aorta had significantly lower compliance, distensibil-
ity and a higher stiffness index – all indicators of
decreased mechanical and intrinsic elastic function. This
functional abnormality strongly correlated with BMI, fat
mass, leptin, waist circumference and HDL levels. Even
after adjustment for the potential confounders of gender
and height, fat mass emerged as the strongest predictor of
decreased aortic elasticity, closely followed by leptin, BMI
and HDL.
Previous studies of obesity have been largely limited to
peripheral vessels, and usually examined obese cohorts
with concomitant insulin resistance [26,27], diabetes [27-
29], hypercholesterolaemia [27] and hypertension
[30,31]. Furthermore, conflicting results on the relation-
ship between increasing BMI, adiposity and vascular stiff-
Mean aortic compliance had a negative correlation with (a) body mass index (BMI), (b) fat mass and (c) leptin Figure 2
Mean aortic compliance had a negative correlation with (a) body mass index (BMI), (b) fat mass and (c) leptin.Journal of Cardiovascular Magnetic Resonance 2008, 10:10 http://www.jcmr-online.com/content/10/1/10
Page 6 of 8
(page number not for citation purposes)
ness have been published. Oren et al [30] reported
increased aortic compliance in obese subjects compared
with lean controls and Raison et al [32] demonstrated
reduced vascular peripheral resistance in obesity. More
recent studies have evaluated arterial distensibility in
peripheral vessels [3] and pulse wave velocities [33] and
suggest a negative correlation between fat mass and aortic
compliance, more consistent with an adverse impact of
obesity on the vasculature.
Oren et al used diastolic blood pressure decay and pulse
pressure relative to stroke volume as surrogate measures
of compliance of the whole aorta. These were measured by
placing a pressure catheter in the ascending aorta. Mag-
netic resonance imaging has the advantage of studying
changes in aortic compliance in different segments of the
aorta. Using CMR, Danias et al [5] studied the ascending
aorta in an obese population with cardiac risk factors and
reported no difference in compliance compared to con-
trols. However, they did find a reduction in elasticity of
the abdominal aorta. They hypothesised that the changes
may have been due to physical compression by abdomi-
nal fat or structural changes in the vessel wall. As the study
included subjects with cardiac risk factors these may also
have independently influenced vascular function. Our
study demonstrates that changes in distensibility occur in
the descending thoracic aorta as well as the abdominal
aorta and are independent of abdominal size. These find-
ings suggest the changes in aortic function are less likely
to be due to physical compression from abdominal fat.
Furthermore, our cohort did not have cardiac risk factors,
which suggests obesity has an independent impact on vas-
cular function.
Similar to Danias et al [5] we found no change in function
in the proximal aorta. The precise reason for the proximal
sparing of the vessel remains unclear. It is possible that
aortic dysfunction in obesity begins distally with an
ascending pattern of progression. The aorta is a physiolog-
ically heterogeneous vessel with elastin:collagen ratios
decreasing distally along its length. Regions with higher
proportions of elastin have physiologically greater abili-
ties to stretch and recoil. Impairment of vascular elasticity
might commence in vessel sections physiologically less
compliant [34], and this might then affect the entire arte-
rial tree if obesity is sustained.
Although we excluded all subjects with raised glucose or
insulin resistance, our population was hyperinsulinaemic.
In work done by Ferrannini et al [35], it was recognised
that although insulin hypersecretion can occur in adults
with uncomplicated obesity, the prevalence of insulin
resistance is low. Further, it was suggested that in the
obese with no evidence of insulin resistance, the risk for
the development of cardiovascular disease might differ
from that seen in the insulin resistant patient. Addition-
ally work done during the San Antonio Heart Study [36]
demonstrated that during an eight year prospective trial,
Mean aortic distensibility correlated negatively with (a) body mass index (BMI) and (b) fat mass Figure 3
Mean aortic distensibility correlated negatively with (a) body mass index (BMI) and (b) fat mass.Journal of Cardiovascular Magnetic Resonance 2008, 10:10 http://www.jcmr-online.com/content/10/1/10
Page 7 of 8
(page number not for citation purposes)
subjects with high HOMA scores (i.e. with evidence of
insulin resistance) were the ones at highest risk for cardi-
ovascular events.
The reduced aortic compliance and distensibility seen in
individuals with uncomplicated obesity was unrelated to
the inflammatory status, as CRP was not correlated to aor-
tic function. Anthropometric parameters and leptin were
the strongest predictors of aortic function and therefore
may be more important in the pathogenesis of early aortic
disease. Elevated leptin has been shown to increase
atherosclerotic risk [37,38]. Knudson et al [39] demon-
strated the presence of leptin receptors on coronary artery
endothelium and that through increased endothelial oxi-
dative stress hyperleptinaemia resulted in significant arte-
rial endothelial dysfunction. Additionally, Zarkesh-
Esfanai et al [40] have demonstrated that high leptin levels
may lead to the activation of tumour necrosis factor alpha
(TNFα). TNFα has been shown to decrease eNOS produc-
tion and consequently increase vascular tone [41]. We
have not measured TNFα but it is conceivable that chron-
ically elevated leptin levels indirectly impair vascular elas-
tic function via TNFα.
Abnormal aortic function is an independent predictor of
the development of coronary artery disease and stroke
[42], as well as left ventricular dysfunction. Interestingly,
cardiac changes are not yet evident in our cohort with
obesity despite a mean age of forty nine. The development
of cardiac dysfunction may have been delayed by the
absence of other risk factors or the selection of subjects
with uncomplicated obesity has identified a specific group
with adaptive processes that compensate for changes in
aortic function. It would be of interest to determine
whether cardiovascular disease and risk factors in obese
individuals predisposes them to further decline in aortic
function and determine how aortic dysfunction
progresses over time in uncomplicated obesity.
Our study is limited by a relatively small sample size and
these findings need to be investigated further in larger
cohorts with uncomplicated obesity. The lack of variation
in left ventricular function between the obese and lean
subjects has been demonstrated in other studies [43].
However, with larger sample numbers to facilitate gender
and obesity subgroup analysis on the basis of increasing
BMI, a pattern towards worsening left ventricular function
might have been noted. As changes in aortic distensibility
are seen so early, it is possible that genetic factors are rele-
vant to changes in aortic distensibility in obesity. Data on
family history of cardiovascular disease was not available
in our cohort and more detailed work will be required to
investigate the possible contribution of inherited factors.
Fat mass distribution is of interest to risk of cardiovascular
disease [44] and can be assessed with magnetic resonance
imaging. Future magnetic resonance research could incor-
porate these measures to determine how adiposity distri-
bution contributes to changes in aortic function. This
research could also study other indices of aortic function
such as pulse wave velocity and more refined assessments
of blood pressure, including use of central aortic pressure.
As leptin is produced predominantly in adipocytes, a
reduction in fat mass, rather than absolute weight reduc-
tion, might be more efficacious in restoring normal aortic
function in this group of patients.
CMR is an excellent imaging modality for non-invasive
quantitative assessment of vascular mechanics in a clinical
study setting, but might prove impractical for screening
for increased aortic stiffness in the general obese popula-
tion. Our study suggests fat mass and BMI have a predic-
tive potential for central arterial dysfunction. Unlike HDL
and leptin measurements, which, though predictive,
necessitate venepuncture and laboratory testing, BMI and
fat mass are both easily measured with scales, callipers or
bioelectric impedance. Earlier appreciation of the vascular
risk posed by uncomplicated obesity encourages earlier
and more aggressive treatment, thus reducing the morbid-
ity and mortality associated with excess body weights.
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